EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

National Trends and Predictors of Adverse Outcomes in Hypoglycemia Hospitalizations in the United States, 2017–2022

Abu Huraira Bin Gulzar iD, Sheraz Hakeem iD, Muhammad Umer Sohail iD, Aima Tahir iD, Tamseer Tariq iD, Rasheeda Shehroz iD, Moiz Shah Khan iD, Ismail Rahim iD, Umme Aiman iD, Muhammad Afnan Ashraf iD, Shanzey Rai iD, Marriam Mavora und 2 weitere

Endocrinology, Diabetes & Metabolism · 2026

DOI: 10.1002/edm2.70370 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism, 2026. Verfasst von Abu Huraira Bin Gulzar und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Services Institute of Medical Sciences, Lahore, Pakistan. Hauptthemen laut MEDLINE: Hypoglycemia, Hospitalization. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess national trends and inpatient outcomes among adults hospitalized with a primary diagnosis of hypoglycemia in the United States from 2017 to 2022.

Methods

We conducted a retrospective cross‐sectional analysis of the National Inpatient Sample. Adult hospitalizations aged 18 years or older with a principal ICD‐10‐CM diagnosis of hypoglycemia were included. The annual share of primary hypoglycemia hospitalizations was calculated per 100,000 adult NIS discharges. Outcomes included in‐hospital mortality, length of stay(LOS), and inflation‐adjusted hospital cost standardized to 2022 US dollars. Multivariable survey‐weighted logistic regression was used for mortality, a survey‐weighted generalized linear model (GLM) with a quasi‐Poisson distribution and log link was used for LOS, and a survey‐weighted GLM with a gamma distribution and log link was used for inflation‐adjusted hospital cost.

Results

The analysis included 330,910 weighted hypoglycemia hospitalizations. Mean age was 67 years; 52% were women; and 70% were Medicare‐insured. Diabetes mellitus (91%) was the most common comorbidity, while obesity (17%) was least common. Primary‐hypoglycemia discharges peaked in 2019 (195 per 100,000 adult NIS discharges), declined in 2021 (180), and increased again in 2022 (190). Mortality occurred in 1.6%, and median LOS was 3 days. Compared with 2017, adjusted mortality odds were higher in 2020 (OR 1.30, 95% CI 1.04–1.61), 2021 (OR 1.44, 95% CI 1.16–1.79), and 2022 (OR 1.33, 95% CI 1.07–1.65). Similarly, LOS and hospital costs were also higher in 2020, 2021, and 2022 compared to 2017. Congestive heart failure (CHF) and AF were associated with higher mortality odds, LOS, and cost.

Conclusion

Primary hypoglycemia hospitalizations declined during the pandemic years but became more severe and resource‐intensive over time. Patients with CHF or AF had higher mortality, higher LOS, and higher hospital costs, highlighting the need for integrated hypoglycemia surveillance and cardiometabolic care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypoglycemiaHospitalizationHumansUnited StatesFemaleRetrospective StudiesCross-Sectional StudiesHospital MortalityAgedMaleLength of StayMiddle AgedHospital CostsAdult

Stichwörter der Autor:innen

National inpatient samplehealthcare costshospitalizationhypoglycemiain‐hospital mortality

Autor:innen und Institutionen

  • Department of Medicine, Services Institute of Medical Sciences, Lahore, Pakistan.
  • Department of Medicine, Aga Khan University Medical College, Karachi, Pakistan.
  • Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
  • Department of Medicine, Akhtar Saeed Medical College, Lahore, Pakistan.
  • Department of Medicine, Karachi Medical and Dental College, Karachi, Pakistan.
  • Department of Medicine, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan.

ORCID-Profile: Abu Huraira Bin Gulzar, Sheraz Hakeem, Muhammad Umer Sohail, Aima Tahir, Tamseer Tariq, Rasheeda Shehroz, Moiz Shah Khan, Ismail Rahim, Umme Aiman, Muhammad Afnan Ashraf, Shanzey Rai, Asad Ali Ahmed Cheema, Hina Nadeem

Zitieren

APA

Bin Gulzar, A. H., Hakeem, S., Sohail, M. U., Tahir, A., Tariq, T., Shehroz, R., Khan, M. S., Rahim, I., Aiman, U., Ashraf, M. A., Rai, S., Mavora, M., Cheema, A. A. A., & Nadeem, H. (2026). National Trends and Predictors of Adverse Outcomes in Hypoglycemia Hospitalizations in the United States, 2017–2022. Endocrinology, Diabetes & Metabolism. https://doi.org/10.1002/edm2.70370

Vancouver

Bin Gulzar AH, Hakeem S, Sohail MU, Tahir A, Tariq T, Shehroz R, et al. National Trends and Predictors of Adverse Outcomes in Hypoglycemia Hospitalizations in the United States, 2017–2022. Endocrinology, Diabetes & Metabolism. 2026. doi:10.1002/edm2.70370

BibTeX
@article{BinGulzar2026,
  author = {Bin Gulzar, Abu Huraira and Hakeem, Sheraz and Sohail, Muhammad Umer and Tahir, Aima and Tariq, Tamseer and Shehroz, Rasheeda and Khan, Moiz Shah and Rahim, Ismail and Aiman, Umme and Ashraf, Muhammad Afnan and Rai, Shanzey and Mavora, Marriam and Cheema, Asad Ali Ahmed and Nadeem, Hina},
  title = {National Trends and Predictors of Adverse Outcomes in Hypoglycemia Hospitalizations in the United States, 2017–2022},
  journal = {Endocrinology, Diabetes & Metabolism},
  year = {2026},
  doi = {10.1002/edm2.70370}
}
Kostenlos starten →